This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Pamela Holland, PhD
Senior Vice President, Biology at InduPro
Speaker

Profile

Pamela Holland, PhD, joined InduPro as SVP of Biology in 2023. Prior to InduPro she was SVP Research at Alpine Immune Sciences and prior to Alpine served as VP of Cancer Biology at Surface Oncology in Cambridge MA. Dr. Holland has a deep background in identifying and validating oncology and autoimmune drug targets and in transitioning drug discovery programs through lead optimization to early clinical development. She earned her PhD from the University of Washington/Fred Hutchinson Cancer Research Center followed by a post-doctoral position at Immunex. Following the acquisition of Immunex by Amgen, she spent many years advancing discovery programs in Oncology research. Prior to graduate school, she was also a key contributor to the development of PCR applications and TaqMan™at Cetus Corporation. She is a co-inventor on all TaqMan patents and was the lead author on the first publication describing TaqMan in 1991.